SENESCOSouth Eastern New England Shipbuilding Corporation
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
Additional terms of this offering (including the material terms of the securities purchase agreement and a description of the warrants issued in connection with this offering) were disclosed on a Form 8-K filed with the SEC by Senesco simultaneously with this press release and will also be disclosed in the prospectus filed with the SEC in connection with this offering.
BioCorp Ventures LLC, a division of technology company US Equity Holdings, has signed a research and development agreement with Senesco Technologies Inc (NYSE Amex: SNT).
Browne, Ph.D., Senesco's president and chief executive officer.
30 March 2010 - Ladenburg Thalmann & Co has been hired as sole agent for the private placement of preferred stock and warrants of Senesco Technologies (AMEX:SNT), the US biotechnology firm said.
Senesco has previously reported positive preclinical in vivo results using its combination siRNA and plasmid against subcutaneous multiple myeloma tumors in immunodeficient mice.
Broin will pay Senesco an annual fee for each facility that incorporates the gene technology, with Senesco estimating that if all of Broin's plants adopt the technology, it would translate into annual payments of more than $1 million.
Senesco unveiled a binding letter of intent (LoI) on the transaction at the end of December 2013, under which the shareholders of both firms were to receive an equal 50% stake in the combined firm.
Senesco Technologies Inc (OTCBB:SNTI), a clinical-stage biotech company specialising in cancer therapeutics, announced on Monday that it has agreed to terms and executed a non-binding Letter of Intent to merge with Fabrus Inc, a privately-held biotechnology company.
Senesco primarily intends to utilize the proceeds of this private placement as an initial step to help advance its research in multiple myeloma with the goal of initiating a Phase I clinical trial.
Senesco Technologies, Inc., New Brunswick, N.J., has appointed Bruce C.
Biotech company Senesco Technologies (OTC BB:SNTI) revealed on Wednesday the election of Ronald A.